NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway

Cellular Signalling

Volumn 25, Issue 1, 2013, Pages 12-18

  Eide, Peter W ^a,b   Cekaite, Lina ^a,b   Danielsen, Stine A ^a,b   Eilertsen, Ina A ^a,b   Kjenseth, Ane ^a,b   Fykerud, Tone A ^a,b   Ågesen, Trude H ^a,b   Bruun, Jarle ^a,b   Rivedal, Edgar ^a,b   Lothe, Ragnhild A ^a,b   Leithe, Edward ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

AKT; Colorectal cancer; NEDD4; PI3K; PTEN; Ubiquitin

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE NEDD4;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL STRUCTURE; CELLULAR DISTRIBUTION; COLON; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEDD4 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PRINCIPAL COMPONENT ANALYSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; UP-REGULATION;

EID: 84867611944     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.08.012     Document Type: Article

References (39)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011, 61:69-90.
2. Muto T., Bussey H.J.R., Morson B.C. The evolution of cancer of the colon and rectum. Cancer 1975, 36:2251-2270.
3. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
4. Danielsen S.A., Cekaite L., Ågesen T.H., Sveen A., Nesbakken A., Thiis-Evensen E., Skotheim R.I., Lind G.E., Lothe R.A. Phospholipase C isozymes are deregulated in colorectal cancer-insights gained from gene set enrichment analysis of the transcriptome. PLoS One 2011, 6:e24419.
5. Kanehisa M. Post-genome Informatics 2000, Oxford University Press, New York, NY.
6. Kerscher O., Felberbaum R., Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annual Review of Cell and Developmental Biology 2006, 22:159-180.
7. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nature Reviews. Cancer 2006, 6:369-381.
8. Li W., Bengtson M.H., Ulbrich A., Matsuda A., Reddy V.A., Orth A., Chanda S.K., Batalov S., Joazeiro C.A.P. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One 2008, 3:e1487.
9. Hoeller D., Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009, 458:438-444.
10. Rotin D., Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nature Reviews Molecular Cell Biology 2009, 10:398-409.
11. Kumar S., Tomooka Y., Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochemical and Biophysical Research Communications 1992, 185:1155-1161.
12. Cao X.R., Lill N.L., Boase N., Shi P.P., Croucher D.R., Shan H., Qu J., Sweezer E.M., Place T., Kirby P.A., Daly R.J., Kumar S., et al. Nedd4 controls animal growth by regulating IGF-1 signaling. Science Signaling 2008, 1(ra5).
13. Fouladkou F., Lu C., Jiang C., Zhou L., She Y., Walls J.R., Kawabe H., Brose N., Henkelman R.M., Huang A., Bruneau B.G., Rotin D. The ubiquitin ligase Nedd4-1 is required for heart development and is a suppressor of thrombospondin-1. Journal of Biological Chemistry 2010, 285:6770-6780.
14. Wang X., Trotman L.C., Koppie T., Alimonti A., Chen Z., Gao Z., Wang J., Erdjument-Bromage H., Tempst P., Cordon-Cardo C., Pandolfi P.P., Jiang X. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007, 128:129-139.
15. Amodio N., Scrima M., Palaia L., Salman A.N., Quintiero A., Franco R., Botti G., Pirozzi P., Rocco G., De Rosa N., Viglietto G. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas. American Journal of Pathology 2010, 177:2622-2634.
16. Bernassola F., Karin M., Ciechanover A., Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 2008, 14:10-21.
17. Yuan T.L., Cantley L.C. PI3K pathway alterations in cancer: variations on a theme. Oncogene 2008, 27:5497-5510.
18. Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. PNAS 1999, 96:4240-4245.
19. Danielsen S.A., Lind G.E., Bjørnslett M., Meling G.I., Rognum T.O., Heim S., Lothe R.A. Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation-status. Human Mutation 2008, 29:E252-E262.
20. Forbes S.A., Bindal N., Bamford S., Cole C., Kok C.Y., Beare D., Jia M., Shepherd R., Leung K., Menzies A., Teague J.W., Campbell P.J., et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Research 2011, 39:D945-D950.
21. Wang Z.H., Gao Q.Y., Fang J.Y. Loss of PTEN expression as a predictor of resistance to anti-EGFR monoclonal therapy in metastatic colorectal cancer: evidence from retrospective studies. Cancer Chemotherapy and Pharmacology 2012, 69:1647-1655.
22. Trotman L.C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N.P., Carver B.S., Cordon-Cardo C., Erdjument-Bromage H., Tempst P., Chi S.G., et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007, 128:141-156.
23. Fouladkou F., Landry T., Kawabe H., Neeb A., Lu C., Brose N., Stambolic V., Rotin D. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. PNAS 2008, 105:8585-8590.
24. Maddika S., Kavela S., Rani N., Palicharla V.R., Pokorny J.L., Sarkaria J.N., Chen J. WWP2 is an E3 ubiquitin ligase for PTEN. Nature Cell Biology 2011, 13:728-733.
25. Ågesen T.H., Sveen A., Merok M.A., Lind G.E., Nesbakken A., Skotheim R.I., Lothe R.A. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut 2012, 61:1560-1567.
26. Berg M., Danielsen S.A., Ahlquist T., Merok M.A., Ågesen T.H., Vatn M.H., Mala T., Sjo O.H., Bakka A., Moberg I., Fetveit T., Mathisen O., et al. DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One 2010, 5:e13978.
27. Leithe E., Cruciani V., Sanner T., Mikalsen S.O., Rivedal E. Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C. Carcinogenesis 2003, 24:1239-1245.
28. Gao S., Alarcon C., Sapkota G., Rahman S., Chen P.Y., Goerner N., Macias M.J., Erdjument-Bromage H., Tempst P., Massagué J. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Molecular Cell 2009, 36:457-468.
29. Li J.Q., Wu F., Masaki T., Kubo A., Fujita J., Dixon D.A., Beauchamp R.D., Ishida T., Kuriyama S., Imaida K. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors. International Journal of Oncology 2004, 25:87-95.
30. Fujita T., Ikeda H., Taira N., Hatoh S., Naito M., Doihara H. Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. BMC Cancer 2009, 9:87.
31. Iwatsuki M., Mimori K., Ishii H., Yokobori T., Takatsuno Y., Sato T., Toh H., Onoyama I., Nakayama K.I., Baba H., Mori M. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. International Journal of Cancer 2010, 126:1828-1837.
32. Diep C.B., Kleivi K., Ribeiro F.R., Teixeira M.R., Lindgjærde O.C., Lothe R.A. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes, Chromosomes and Cancer 2006, 45:31-41.
33. Gao C., Pang L., Ren C., Ma T. Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient. Medical Oncology 2012, 29:1733-1738.
34. He S., Deng J., Li G., Wang B., Cao Y., Tu Y. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma. Japanese Journal of Clinical Oncology 2012, 42:196-201.
35. Kim S.S., Yoo N.J., Jeong E.G., Kim M.S., Lee S.H. Expression of NEDD-1, a PTEN regulator, in gastric and colorectal carcinomas. APMIS 2008, 116:779-784.
36. Naguib A., Cooke J.C., Happerfield L., Kerr L., Gay L.J., Luben R.N., Ball R.Y., Mitrou P.N., McTaggart A., Arends M.J. Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors. BMC Cancer 2011, 11:123.
37. Song M.S., Salmena L., Pandolfi P.P. The functions and regulation of the PTEN tumour suppressor. Nature Reviews Molecular Cell Biology 2012, 13:283-296.
38. Kawabe H., Neeb A., Dimova K., Young J., Takeda M., Katsurabayashi S., Mitkovski M., Malakhova O.A., Zhang D.E., Umikawa M., Ki Kariya, Goebbels S., et al. Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development. Neuron 2010, 65:358-372.
39. Taira K., Umikawa M., Takei K., Myagmar B.E., Shinzato M., Machida N., Uezato H., Nonaka S., Ki Kariya The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton. Journal of Biological Chemistry 2004, 279:49488-49496.